Abstract
The majority of cases of Acute Lymphoblastic Leukemia (ALL) demonstrate an abnormal karyotype, either in chromosome number (ploidy) or structural changes such as translocations, inversions or deletions, or both. The majority of cytogenetic changes are seen in B precursor ALL with only 39% occurring in T-ALL. Hyperdiploidy being the most common numerical abnormality, hypodiploid, pseudodiploid, near triploid changes are also seen. Multiple structural abnormalities including t(4;11), t(11;19), t(17;19), t(10:14), t(11;14), t(8;14) and t(12;21) as well as i(7q),i(9q),i(17q), and i(21q) are seen. Complex karyotypes are also seen in some cases.
The following case studies illustrate many of these abnormalities (Annexure).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gibbons B. High hyperdiploid acute lymphoblastic leukemia. Atlas Genet Cytogenet Oncol Haematol. 1999;3(3):145–6.
Paulsson K. High hyerdiploid childhood acute lymphoblastic leukemia: chromosomal gains as the main driver event. Mol Cell Oncol. 2016;3(1):e1064555.
Raynaud, et al. Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia. 1999;13:1325–30.
Romana SP, Poirel H, Leconiat M, et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood. 1995;86(11):4263–9.
Huret JL, Bernheim A. t(12;21)(p13;q22), Atlas Genet Cytogenet Oncol Haematol. 1997;1(1).
Yadav A, Bhargava M. High hypodiploidy karyotype showing t(9;22) (q34,q11.2) along with monosomy 7 in adult ALL. ASH Image Bank Published date 08/07/2018.
Heerema NA, Harbott J, Galimberti S, et al. Secondary cytogenetic aberrations in childhood, Philadelphia chromosome positive acute lymphoblastic leukemia are non random and may be associated with outcome. Leukemia. 2004;18(4):693–702.
Achkar W, Wafa A, Othman M. An adult B cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations. Mol Cytogenet Published online. 2014. https://doi.org/10.1186/s13039-014-0060-0
Raynaud SD, Cave H, Baens M, et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood. 1996 May;87(7):2891–9.
Raynaud SD, Dastugue N, Zoccola D, et al. Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia. 1999;13:1325–30.
Wafa A, Assad M, Liehr T. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q23;p13.3)and two additional chromosome aberrations involving chromosomes 1,6,13: a case report. J Med Case Rep. 2017;11:94.
Borowitz MJ. B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities: WHO classification of Tumours of Haematopoietic and lymphoid tissues (revised 4th ed). IARC: Lyon; 2017.
Uckun FM, Sensel MG, Sather HN. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children’s Cancer group. 1998;16(2)527–35.
Mohamed A. N: del (9p) in acute lymphoblastic leukemia. Atlas Genet Cytogenet Oncol Haematol. 2017;21(7):252–5.
Iacobucci I, Papayannidis C, Lonetti A. Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments. Current Haematol Malig Rep. 2012;7:133–43.
Mohamed AN. dup(1q) in ALL. Atlas Genet cytogenet Oncol Hemato. 2018;22(6):255–9.
Yamamoto K, Kawamoto S, Mizutani Y, et al. Mixed phenotype acute leukemia with t(12;17) (p13;q21) TAF15-ZNF384 and other chromosome abnormalities. Cytogenet Genome Res. 2016;149(3):165–70.
Kim J, Kim HS, Choi JR. t(12;17) (p13;q12) /TAF15-ZNF 384 in acute lymphoblastic leukemia. Ann Lab Med. 2016;36(4):396–8.
Safavi S, et al. Genetic and epigenetic characterisation of hypodiploid acute lymphoblastic leukemia. Oncotarget. 2015;6:42793–802.
Aldoss I, Stiller T, Cao TM, et al. The impact of additional cytogenetic abnormalities in adult with Philadelphia Chromosome-positive acute lymphoblastic leukemia undergoing allergenic hematopoietic cell transplantation. Brol Blood Marrow Transplant. 2015;21(7):1326–1329.
Achkar W, Wafa A, Othman M. An adult B cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations. Mol Cytogenet. 2014;7:60. https://doi.org/10.1186/s13039-014-0060-0.
Hoelzer D, Gokbuget N. New approaches to acute lymphoblastic leukemia in adults: where do we go? Seminar Oncol. 2000;27:540–59.
Aldoss I, Stiller T, Tsai NC, et al. Therapy- related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de-novo acute lymphoblastic leukemia but outcomes are comparable in transplanted patients. Haematologica. 2018;103(10):1662–8.
Ribera JM. Therapy related acute lymphoblastic leukemia haematologica. 2018;103(10):1581–3.
Neumann M, Heesch S, Gokbuget N, et al. Clinical and molecular risk subgroup in adult Characterisation of early T-cell precursor leukemia: a high of FLT3 mutations. Blood Cancer J. 2012;2:e55.
Gilliland DG, Groffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100:1532–42.
Heerema NA, Sather HN, Sensel MG, et al. Association of chromosome 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 1999;94(5):1537–44.
Paulson K, Lilljebjor H, Biloglav A, et al. The genomic landscape of high hyerdiploid childhood acute lymphoblastic leukemia. Nat Genet. 2015;47:672–6.
Paulson K. High hyperdiploid childhood acute lymphoblastic leukemia: chromosomal gains as the main driver event. Mol Cell Oncol. 2016;3(1):e1064555.
Hof J, Groeneveld-Krentz S, Schewick C, et al. Mutations and deletions of the TP53 gene predict non response to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia. J Clin Oncol. 2011; 29(23):3185–93.
Sanjuan PA, Bueno C, Prieto C, et al. Revisiting the biology of infant t(4;11)/MLL-AF4+B-cell acute lymphoblastic leukemia. Blood. 2015;126(25):2676–85.
Greaves M. When one mutation is all it takes. Cancer Cell. 2015;27(4):433–4.
Bardini M, Woll PS, Corral L, et al. Clonal variegation and dynamic competition of leukemia initiating cells in infant acute lymphoblastic leukemia with MLL rearrangements. Leukemia. 2015;29(1).
Raimondi SC. 11q23 rearrangements in childhood acute lymphoblastic leukemia. Atlas Genet Cytogenet Oncol Haematol. 2004;8(2):97–102.
Safavi S, Paulson K. Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis. Blood. 2017;129(4):420–3.
Wetzler M, Dodge R, Morozek K, et al. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia. Group B Br J Haematol. 2004;124(3):275–88.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th ed). IARC: Lyon; 2017.
Kawahara Y, Iioka F, Fukutsuka K, et al. Masked Philadelphia chromosome in acute lymphoblastic leukemia. Tenri Med Bull. 2015;18(1):36–9.
Huret JL. t(9,22) (q34;q11) in ALL. Atlas Gunet Cytogenet Oncol Haematol. 1997;1(1):26–8.
Yilmaz M, Kantarjian H, et al. Philadelphia chromosome positive acute lymphoblastic leukemia in adults: current treatments and future perspectives. Clin Adv Hematol Oncol. 2018;16(3).
Ravandi F, Kebriael P. Phildelphia chromosome positive acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(5).
Kantarjian HM, Talpraz M, Dhingra K. Significance of the P210 versus P 190. Molecular abnormalities in adults with Philadelphia chromosome positive acute leukemia. Blood. 1991;78:2411–8.
Barber KE, Harrison CJ, Broadfield ZJ, et al. Molecular cytogenetic characterization of TCF3 (E2A/19P13.3) rearrangements B cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2007;46(5):478–86.
Tirado CA, Shabsovich D, Yeh L, et al. A t(1:29) translocation involving TCF3-PBx1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of literature. Biomark Res. https://doi.org/10.1186/s40364-015-0029-0
AL-Achkar W, Wafa A, Liehr T. An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations. Mol Cytogenet. 2014;7:60.
Zamecnikova A. i(8)(q10) on ALL. Atlas Genet Cytogenet Oncol Haematol. 2018;22(8):336–40.
Ravandi F, Kebriaei P. Philadelphia chromosome positive acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(5):1043–63.
Van Der Berg E. Marian Stevens-Kroef: t(8:14) (q23:q32) / t(2;8) (p12;q24)/t(8;22) q(24;q11). Atlas Genet Cytogenes Oncol Haematol. 2017;21(2):56–9.
Abe R, Tebbi CK, Yasuda H, et al. North American Burkitt type ALL with a variant translocation t(8;22). Cancer Genet. 1982;7(3):185–95.
Ko Bor S, Tang JL, Lee FY. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome / BCR-ABL positive acute lymphoblastic leukemia in Taiwan. Am J Hemat. 2002;71:291–9.
Walters R, Kantarjian HM, Keating MJ. The importance of cytogenetic studies in adult acute lymphoblastic leukemia. Am J Med. 1990;89:579–87.
Bacher U, Haferlach T, Hiddemann W. Additional clonal abnormalities in Ph+ALL and CML demonstrate a different cytogenetic pattern at diagnosis and fellow at different pathways at progression. Cancer Genet. 2005;157(1):53–61.
Collaborative study of karyotype in childhood acute lymphoblastic leukemia. Groupe Francais de cytogenetique Hematologique. Leukemia. 1993;7(1):10–9.
Jarosova M, et al. Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases. Cancer Genet Cytogenetics. 2003;145(2):161–8. https://doi.org/10.1016/S0165-4608(03)00099-2.
Toboso DG, Campos CB. Peripheral eosinophilia as the first manifestation of B-cell acute lymphoblastic leukemia with t(5;14) (q31;q32). Blood. 2017;130:380. https://doi.org/10.1182/blood-2016-12-754812.
Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin- 3 gene to the immunoglobulin heavy chain gene. Blood. 1989;73:2081–5. https://doi.org/10.1182/blood.V73.8.2081.2081.
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organisation classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.
Author information
Authors and Affiliations
Annexure
Annexure
-
Case Study 9.1 Acute Lymphoblastic Leukemia with High Hyperdiploidy
-
Case Study 9.2 Acute Lymphoblastic Leukemia with complex karyotype with t(12;21) (ETV6/RUNX1)
-
Case Study 9.3 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia with Hypodiploidy, Monosomy 7, and der 6 t(2;6)
-
Case Study 9.4 Acute Lymphoblastic Leukemia with normal Karyotype with t(12;21) on FISH
-
Case Study 9.5 Acute Lymphoblastic Leukemia with t (1;19) (q23;p13.3) and i(1)(q10)
-
Case Study 9.6 Acute Lymphoblastic Leukemia with del(9p) and dup (1q)
-
Case Study 9.7 Relapsed Precursor B Acute Lymphoblastic Leukemia with t(12;17)(p13;q11.2)
-
Case Study 9.8 Philadelphia Chromosome positive Acute Lymphoblastic Leukemia with High Hypodiploidy with Monosomy 7
-
Case Study 9.9 Therapy Related Acute Lymphoblastic Leukemia with Complex Karyotype
-
Case Study 9.10 Early T Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) with Normal Karyotype and FLT3-ITD Mutation Positive
-
Case Study 9.11 Acute Lymphoblastic Leukemia with del (9p)
-
Case Study 9.12 Acute Lymphoblastic Leukemia with High Hyperdiploidy with Complex Karyotype and TP53 Gene Deletion
-
Case Study 9.13 Acute Lymphoblastic Leukemia with Complex Karyotype with t(4;11) (q21;q23)
-
Case Study 9.14 Acute Lymphoblastic Leukemia with both Hyperdiploid and Hypodiploid Clones
-
Case Study 9.15 Philadelphia Chromosome positive acute Lymphoblastic Leukemia with additional Cytogenetic Abnormalities
-
Case Study 9.16 Acute Lymphoblastic Leukemia with masked t(9;22)
-
Case Study 9.17 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
-
Case Study 9.18 Acute Lymphoblastic Leukemia with der 19 t(1;19) (q23;p13)
-
Case Study 9.19 Acute Lymphoblastic Leukemia with Philadelphia Chromosome t(9;22) (q34;q11.2) with i(8)(q10)and der (5) t (5;8)
-
Case Study 9.20 Acute Lymphoblastic Leukemia / non Hodgkin’s Lymphoma with a Variant t(8;22), MYC/IGL
-
Case Study 9.21 Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia with Composite Karyotype and del(7p)
-
Case Study 9.22 Acute Lymphoblastic Leukemia with Complex Karyotype
-
Case Study 9.23 Acute Lymphoblastic Leukemia with Eosinophilia
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bhargava, M. (2021). Acute Lymphoblastic Leukemia. In: Hematologic Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-33-4799-1_9
Download citation
DOI: https://doi.org/10.1007/978-981-33-4799-1_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4798-4
Online ISBN: 978-981-33-4799-1
eBook Packages: MedicineMedicine (R0)